Connect with us

Hi, what are you looking for?

Economy

“CVS Health Out with Phenylephrine: Goodbye Decongestants!

CVS Health, one of the largest retail pharmacies in the United States, has recently made the decision to stop selling decongestants containing phenylephrine. This is a major move due to the fact that phenylephrine is an active ingredient in both over the counter (OTC) and prescription medications used to relieve nasal and sinus congestion.

The decision to no longer carry phenylephrine-containing decongestants has been a long time coming for CVS Health. Studies have shown that phenylephrine is not as effective as other medications, such as pseudoephedrine, for relieving nasal and sinus congestion. CVS Health has also noted that there can be potential safety concerns with phenylephrine, such as an increased risk of stroke and heart attack.

Despite the potential safety concerns, phenylephrine-based decongestants are still widely sold at other retail pharmacies around the country. CVS Health’s decision to no longer carry these decongestants sends a powerful message to the rest of the industry. It shows that CVS Health takes customer safety and product efficacy seriously, and that they are willing to make the necessary changes to ensure their customers are being provided with the best possible care.

The move to no longer offer phenylephrine-containing decongestants is intended to further CVS Health’s mission to deliver accessible and affordable health care. While the removal of these products may not directly result in savings for customers, it does provide a sign that CVS Health is not afraid to act on the research and data that is available.

Overall, it is encouraging to see CVS Health take a step towards providing better health care by no longer offering decongestants containing phenylephrine. It serves as an example for other retailers to follow, so that customers can continue to receive the most effective and safe products available.

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Investing

    Getchell Gold Corp, a junior miner exploring gold mining in Nevada, has just initiated trading on the Frankfurt Exchange under the symbol GGA1. Getchell...

    Latest News

    France has announced the release of François Santoni, a French official that had been held by Niger security forces since July 7. The French...

    Stock

    With government issues, i.e. bonds, it is essential to consider the “long term trend” in order to get the most benefit and create wealth...

    Investing

    Exploration results from the latest Bigfoot Drilling Program at the Tatiggaq Project in Canada’s Thelon Basin, Yukon-Northwest Territories region have demonstrated that the uranium...

    Disclaimer: Incomeinvestingsinsider.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 Incomeinvestingsinsider.com